Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingyi Huaji Recipe plus neoadjuvant chemotherapy for borderline resectable pancreatic cancer
ChiCTR2300077495Phase 2Not yet recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Oct 2023
- Countries
- 1
01
Overview
Phase 2, randomised trial of Qingyi Huaji Recipe in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoint: Objective response rate. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
Qingyi Huaji Recipe
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on ChiCTR2300077495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077495.